GlassScriptPhysician profile
Ross Anthony Leclair
NPI 1679224752
$645.68
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $83.26 · 2023: $183 · 2024: $379.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $562.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $562.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $139.92 | 2022-2024 | Xifaxan |
| Exact Sciences Corporation | $71.95 | 2023-2024 | Cologuard Collection Kit |
| Corcept Therapeutics | $58.65 | 2024 | Korlym |
| Takeda Pharmaceuticals U.S.A., INC. | $54.00 | 2022-2024 | Trintellix |
| Vanda Pharmaceuticals INC. | $43.65 | 2024 | Fanapt, Hetlioz |
| Lundbeck LLC | $33.74 | 2024 | Vyepti |
| Amgen INC. | $30.81 | 2023-2024 | Otezla, Repatha |
| Abiomed | $29.87 | 2024 | Impella |
| Novo Nordisk INC | $28.16 | 2023 | Ozempic |
| Medtronic, INC. | $25.64 | 2024 | Intellis Adaptivestim |
| Novartis Pharmaceuticals Corporation | $18.29 | 2024 | |
| Merck Sharp & Dohme LLC | $18.13 | 2024 | Verquvo |
| Lilly USA, LLC | $16.26 | 2024 | Mounjaro |
| Kyowa Kirin, INC. | $15.91 | 2024 | Crysvita |
| Idorsia Pharmaceuticals US INC | $14.14 | 2024 | Quviviq |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $13.53 | 2023 | Rexulti |
| Astrazeneca Pharmaceuticals LP | $13.32 | 2023 | Fasenra |
| Glaxosmithkline, LLC. | $13.21 | 2022 | |
| Dynavax Technologies Corporation | $6.50 | 2023 | Heplisav-B |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ross Leclair listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.